Rating History for Bristol-Myers Squibb Co. (BMY) by CFRA
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/2/2022 | N/A | Downgrade | Sell (Hold) |
66.00 (N/A) |
77.20 (74.46) |
-3.55% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/2/2022 | N/A | Downgrade | Sell (Hold) |
66.00 (N/A) |
77.20 (74.46) |
-3.55% | Details |
